MedTrace Logo

Chemotherapy Monitoring With Breast Computed Tomography (CT)

NCT00808041 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2015-07-23

No results posted yet for this study

Summary

The purpose of this study is to determine if dedicated breast computed tomography can be used successfully to monitor tumor response in breast cancer patients undergoing neoadjuvant chemotherapy.

Conditions

Interventions

DEVICE

Dedicated breast computed tomography imaging

Pre- and post-contrast enhancement acquisition of breast CT images of tumor-containing breast every two months.

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Emory University

    lead OTHER

Principal Investigators

  • Ioannis Sechopoulos, PhD · Emory University

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2012-09-30
Completion
2015-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00808041 on ClinicalTrials.gov